Ohr制药(OHRP)
5.39 0.00 0.0%
| 今开：0.0 | 昨收：5.39 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.5249647E7 |
Ohr制药的最新讨论
![[俏皮]](http://js.xueqiu.com/ugc/images/face/emoji_04_cool.png?v=1 "[俏皮]"){kind=small}
![[捂脸]](http://js.xueqiu.com/ugc/images/face/emoji_33_face.png?v=1 "[捂脸]"){kind=small}
再涨也不是我的了chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3，NeuBase Therapeutics通过反向收购Ohr Pharmaceutical，在纳斯达克上市。NeuBase的模块化反义肽核酸（PNA）平台PATrOL用于改善基因沉默疗法。网页链接查看全文
Ohr制药的公告
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-04-19 AccNo: 0001387131-17-002150 Size: 21 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2017-04-10,Director,HIRSCHMAN ORIN ,买入,142858普通股, $0.70
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2017-04-10,CFO,Backenroth Samuel ,买入,71429普通股, $0.70
$OHR PHARMACEUTICAL INC(OHRP)$ 内部交易: 2017-04-10,CEO,Slakter Jason Scott ,买入,142858普通股, $0.70
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-04-10 AccNo: 0001387131-17-002008 Size: 64 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 8.01: Other EventsItem 9.01: Financial Statements an...
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-04-06 AccNo: 0001387131-17-001972 Size: 566 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-04-06 AccNo: 0001387131-17-001970 Size: 649 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-04-04 AccNo: 0001387131-17-001901 Size: 652 KB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-04-04 AccNo: 0001387131-17-001897 Size: 313 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-03 AccNo: 0001387131-17-001166 Size: 40 KB 网页链接